metricas
covid
Annals of Hepatology Reply to: “correspondence about “Efficacy and safety of basiliximab”
Journal Information

Statistics

Follow this link to access the full text of the article

Letters to the editor
Reply to: “correspondence about “Efficacy and safety of basiliximab”
Mohamed Hashim
Corresponding author
msaadhh@hotmail.com

Corresponding author.
, Ayman Alsebaey, Amr Ragab, Hossam Eldeen Soliman, Imam Waked
Read
1258
Times
was read the article
339
Total PDF
919
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 15 8 23
2025 11 54 43 97
2025 10 44 21 65
2025 9 33 11 44
2025 8 37 8 45
2025 7 36 6 42
2025 6 26 3 29
2025 5 36 6 42
2025 4 12 1 13
2025 3 15 4 19
2025 2 27 2 29
2025 1 15 1 16
2024 12 16 4 20
2024 11 34 1 35
2024 10 8 5 13
2024 9 9 2 11
2024 8 13 1 14
2024 7 15 9 24
2024 6 15 2 17
2024 5 10 0 10
2024 4 15 9 24
2024 3 23 5 28
2024 2 24 11 35
2024 1 12 3 15
2023 12 14 9 23
2023 11 24 5 29
2023 10 19 10 29
2023 9 3 4 7
2023 8 12 4 16
2023 7 4 4 8
2023 6 22 2 24
2023 5 40 6 46
2023 4 20 6 26
2023 3 27 1 28
2023 2 18 5 23
2023 1 13 12 25
2022 12 14 14 28
2022 11 7 10 17
2022 10 11 8 19
2022 9 10 8 18
2022 8 7 4 11
2022 7 8 9 17
2022 6 21 9 30
2022 5 33 7 40
2022 4 26 17 43
2022 3 16 14 30
2022 2 6 5 11
Show all

Follow this link to access the full text of the article